SCHEMBL4121766

SCHEMBL4121766

O=C(O)Cc1ccc(NC2=NC(=O)C(=Cc3ccc(-n4cnnn4)cc3)S2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
DUSP3 P51452 1/20 0.41
DUSP22 Q9NRW4 1/20 0.41
KCNJ1 P48048 2/20 0.40
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
HTT P42858 1/20 0.37
QPCT Q16769 1/20 0.37
KCNH2 Q12809 1/20 0.37
CYP3A4 P08684 1/20 0.36
LMNA P02545 1/20 0.36
SYK P43405 1/20 0.36
PKM P14618 1/20 0.36
PTPN22 Q9Y2R2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4121763 1.00 ALDH1A1 (0.42) ALDH1A1DUSP3DUSP22KCNJ1RAB9A
Acetic Acid SCHEMBL4137421 0.85 RXFP1 (0.42) ALDH1A1KCNJ1RAB9ASMN1; SMN2KDM4E
Acetic Acid SCHEMBL4137417 0.85 RXFP1 (0.42) ALDH1A1KCNJ1RAB9ASMN1; SMN2KDM4E
SCHEMBL4123875 0.83 POLB (0.51) ALDH1A1DUSP3DUSP22RAB9AKDM4E
SCHEMBL4123871 0.83 POLB (0.51) ALDH1A1DUSP3DUSP22RAB9AKDM4E
SCHEMBL4133860 0.82 DUSP22 (0.49) ALDH1A1DUSP3DUSP22RAB9ASMN1; SMN2
SCHEMBL4133862 0.82 DUSP22 (0.49) ALDH1A1DUSP3DUSP22RAB9ASMN1; SMN2
SCHEMBL4127839 0.81 PDE4B (0.42) DUSP3DUSP22GAAHTTPTPN22
SCHEMBL4127838 0.81 PDE4B (0.42) DUSP3DUSP22GAAHTTPTPN22
SCHEMBL4634749 0.81 ALOX5 (0.52) MEN1KMT2APTPN22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ ALDH1A1 216/4885DUSP3 66/4885DUSP22 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.